Note: Should you have landed here as a result of a search engine (or other) link, be advised that these files contain material that is copyrighted by the American Medical Association. You are forbidden to download the files unless you read, agree to, and abide by the provisions of the copyright statement. Read the copyright statement now and you will be linked back to here.
Contractor's Policy Number
03-09
Contractor's Name
CareFirst of Maryland Inc., Medicare Part A
Contractor Number
00190
Contractor Type
Fiscal Intermediary
LMRP Title
Percutaneous Image-Guided Breast Biopsy
AMA CPT Copyright Statement
CPT codes, descriptions, and other data only are copyright 1999 American Medical Association (or such publication of CPT). All rights reserved. Applicable FARS/DFARS clauses apply.
CMS National Coverage Policy
Primary Geographic Jurisdiction
Secondary Geographic Jurisdiction
Alabama, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Massachusetts, Michigan, Missouri, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Wisconsin, Washington state, and Wyoming
CMS Region
Region III
CMS Consortium
Northeast
Original Policy Effective Date
Original Policy Ending Date
Revision Effective Date
Revision Ending Date
LMRP Description
Percutaneous image-guided breast biopsy is a method of obtaining a breast biopsy through a percutaneous incision by employing image guidance systems. Percutaneous image-guided breast biopsy utilizes ultrasound or stereotactic guidance for needle insertion in a breast lesion that is otherwise located only by an open procedure. This particular type of needle biopsy is chosen according to the characteristics of the lesion.
Indications and Limitations of Coverage and/or Medical Necessity
The Breast Imaging Reporting and Data System (or BIRADS system) employed by the American College of Radiology provides a standardized lexicon with which radiologists may report their interpretation of a mammogram. The BIRADS grading of mammograms is as follows: Grade I-Negative, Grade II-Benign finding, Grade III-Probably benign, Grade IV-Suspicious abnormality, and Grade V-Abnormality.
Nonpalpable Breast Lesions
Effective January 1, 2003, Medicare covers percutaneous image-guided breast biopsy using stereotactic or ultrasound imaging for a radiographic abnormality that is nonpalpable and is graded as a BIRADS III (probably benign), IV (suspicious abnormality), or V (abnormality).
Palpable Breast Lesions
Effective
CPT/HCPCS Section & Benefit Category
Surgery/Radiology
Ambulatory Surgical Center Facility Services
Outpatient Hospital Services Incident to a Physician's Service
Type of Bill Code
13X, 14X
Revenue Codes
30X, 31X
36X, 49X
32X, 33X, 34X, 35X, , 40X, 61X
320 (Use for hospitals not subject to OPPS)
CPT/HCPCS Codes
The AMA and CMS require the use of short descriptors for policies published on the Web. Refer to the CPT book for the long description of the following codes:
|
10022 |
© |
Fine needle asp |
|
19100 |
© |
Biopsy of breast |
|
19101 |
© |
Biopsy of breast |
|
19102 |
© |
Biopsy of breast |
|
19103 |
© |
Biopsy of breast |
|
76095 |
© |
Stereotactic localization |
|
76096 |
© |
Mammographic guidance |
|
76360 |
© |
Computed tomography |
|
76393 |
© |
Magnetic resonance |
|
76942 |
© |
Ultrasonic guidance |
|
88170 |
© |
Fine needle asp |
© CPT American Medical Association
Not Otherwise Classified (NOC)
ICD-9 Codes that Support Medical Necessity
ICD-9-CM code listings may cover a range and include truncated codes. It is the provider’s responsibility to avoid truncated codes by selecting a code(s) carried out to the highest level of specificity and selected from the ICD-9-CM book appropriate to the year in which the claim is submitted.
It is not enough to link the procedure code to a correct, payable ICD-9-CM code. The diagnosis or clinical suspicion must be present for the procedure to be paid.
Medicare is establishing the following limited coverage:
Covered for:
|
611.72 |
|
Lump or mass in breast |
|
793.80 |
|
Abnormal mammogram, unspecified |
|
793.81 |
|
Mammographic microcalcification |
|
793.89 |
|
Other abnormal findings on radiological examination of breast |
Diagnoses that Support Medical Necessity
As listed in the "ICD-9 Codes that Support Medical Necessity" section of this policy.
ICD-9 Codes that DO NOT Support Medical Necessity
Any diagnosis codes not listed in the "ICD-9 Codes that Support Medical Necessity" section of this policy.
Diagnoses that DO NOT Support Medical Necessity
Conditions not listed in the "ICD-9 Codes that Support Medical Necessity" section of this policy.
Reasons for Denial
Non-covered ICD-9 Codes
Any diagnosis codes not listed in the "ICD-9 Codes that Support Medical Necessity" section of this policy
Non-covered Diagnoses
Conditions not listed in the "ICD-9 Codes that Support Medical Necessity" section of this policy.
Coding Guidelines
Documentation Requirements
Utilization Guidelines
Medicare will monitor the utilization of this procedure through the Medical Review process.
Other Comments
This policy was developed based on the National Coverage Determination (NCD) to expand the NCD to include appropriate ICD-9 codes, as they were not a part of the national determination.
Financial Responsibility:
Provider Liable
The provider of the service or the ordering physician must have notified the patient in writing, prior to the service, and obtain a signature verifying the Advance Beneficiary Notice (ABN). Without prior notice, services denied as not medically necessary cannot be billed to the beneficiary and the provider is liable.
Beneficiary Liable
If there is clear evidence that the beneficiary was issued and signed an
Advanced Beneficiary Notice (ABN) prior to the service, the liability rests
with the beneficiary. Claims for dates of service prior to
Claims for dates of service beginning
Reference: PM AB-02-168, CR 2415
Sources of Information and Basis for Decision
Advisory Committee Notes
This policy does not reflect the sole opinion of the contractor or Contractor Medical Director. Although the final decision rests with the contractor, this policy was developed in cooperation with advisory groups , which includes representatives from the appropriate specialty(ies).
Advisory Committee Meeting Date:
Start Date of Comment Period
06/17/2003
End Date of Comment Period
08/01/2003
Start Date of Notice Period
Revision History
|
Number |
|
Date |
|
Change |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
THIS BULLETIN SHOULD BE SHARED WITH ALL HEALTH CARE PRACTITIONERS AND MANAGERIAL MEMBERS OF THE PROVIDER/SUPPLIER STAFF. BULLETINS ISSUED AFTER OCTOBER 1, 1999 ARE AVAILABLE FROM OUR WEBSITE AT www.marylandmedicare.com
Italicized and or quoted material is excerpted from the American Medical Association Current Procedural Terminology CPT codes, descriptions and other data only are copyrighted 1999 American Medical Association (or such other publication of CPT). All rights reserved. Applicable FARS/DFARS apply.